Holen Sie sich die Stockscreener-App
0.6614
5.99%
0.0374
Finanzdaten der Relmada Therapeutics Inc-Aktie (RLMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
43.90%
10.22
|
18.22 | 19.08 | 23.01 | 18.82 |
| Operating Income/Loss |
43.90%
-10.22
|
-18.22 | -19.08 | -23.01 | -18.82 |
| Nonoperating Income/Loss |
46.15%
0.3549
|
0.659 | 0.4184 | 1.2829 | 1.0507 |
| Income/Loss From Continuing Operations Before Tax |
43.81%
-9.8664
|
-17.56 | -18.66 | -21.73 | -17.77 |
| Income/Loss From Continuing Operations After Tax |
43.81%
-9.8664
|
-17.56 | -18.66 | -21.73 | -17.77 |
|
Net Income/Loss
|
43.81%
-9.8664
|
-17.56 | -18.66 | -21.73 | -17.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.15%
33.19
|
30.41 | 0.00351 | 30.17 | 30.17 |
| Diluted Average Shares |
9.15%
33.19
|
30.41 | 0.00351 | 30.17 | 30.17 |
| Basic Earnings Per Share |
48.28%
-0.30
|
-0.58 | -0.62 | -0.72 | -0.59 |
| Diluted Earnings Per Share |
48.28%
-0.30
|
-0.58 | -0.62 | -0.72 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):